
3 min read
Personalized mRNA vaccine triggers lasting immunity in aggressive breast cancer
Personalized mRNA vaccines show lasting T cell immune response in early-stage triple-negative breast cancer patients.
1 article

Personalized mRNA vaccines show lasting T cell immune response in early-stage triple-negative breast cancer patients.